These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 25932591)

  • 1. Sepsis: a roadmap for future research.
    Cohen J; Vincent JL; Adhikari NK; Machado FR; Angus DC; Calandra T; Jaton K; Giulieri S; Delaloye J; Opal S; Tracey K; van der Poll T; Pelfrene E
    Lancet Infect Dis; 2015 May; 15(5):581-614. PubMed ID: 25932591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis: a need for new solutions.
    Bosurgi R
    Lancet Infect Dis; 2015 May; 15(5):498-9. PubMed ID: 25932571
    [No Abstract]   [Full Text] [Related]  

  • 3. Sepsis research and the poorest of the poor.
    Riviello ED; Sugira V; Twagirumugabe T
    Lancet Infect Dis; 2015 May; 15(5):501-3. PubMed ID: 25932573
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing sepsis.
    Szakmany T; Ellis G; Sharif B; Lundin RM; Hall JE
    Lancet Infect Dis; 2015 Nov; 15(11):1260. PubMed ID: 26531032
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing sepsis.
    Bermejo-Martin JF; Andaluz-Ojeda D; Almansa R; Eiros JM; Tamayo E
    Lancet Infect Dis; 2015 Nov; 15(11):1259-60. PubMed ID: 26531031
    [No Abstract]   [Full Text] [Related]  

  • 6. What next for sepsis?
    Daniels R
    Lancet Infect Dis; 2015 May; 15(5):499-501. PubMed ID: 25932572
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal sepsis: an old issue needing new answers.
    Molyneux E; Gest A
    Lancet Infect Dis; 2015 May; 15(5):503-5. PubMed ID: 25932574
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sepsis: new insights into its pathogenesis and treatment].
    Wiersinga WJ; van der Poll T
    Ned Tijdschr Geneeskd; 2010; 154():A1130. PubMed ID: 20170566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
    Rello J; van Engelen TSR; Alp E; Calandra T; Cattoir V; Kern WV; Netea MG; Nseir S; Opal SM; van de Veerdonk FL; Wilcox MH; Wiersinga WJ
    Clin Microbiol Infect; 2018 Dec; 24(12):1264-1272. PubMed ID: 29581049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis.
    Huttunen R; Aittoniemi J
    J Infect; 2011 Dec; 63(6):407-19. PubMed ID: 21840338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic, immunologic, and clinical aspects of sepsis - update 2016.
    Uhle F; Chousterman BG; Grützmann R; Brenner T; Weber GF
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):917-27. PubMed ID: 27530423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why have clinical trials in sepsis failed?
    Marshall JC
    Trends Mol Med; 2014 Apr; 20(4):195-203. PubMed ID: 24581450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for the treatment of sepsis.
    Heming N; Lamothe L; Ambrosi X; Annane D
    Expert Opin Emerg Drugs; 2016; 21(1):27-37. PubMed ID: 26751198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis in the 21st century: recent definitions and therapeutic advances.
    Nguyen HB; Smith D
    Am J Emerg Med; 2007 Jun; 25(5):564-71. PubMed ID: 17543662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.